Pluripotent stem cells in disease modelling and drug discovery

Y Avior, I Sagi, N Benvenisty - Nature reviews Molecular cell biology, 2016 - nature.com
Experimental modelling of human disorders enables the definition of the cellular and
molecular mechanisms underlying diseases and the development of therapies for treating …

Down syndrome: an insight of the disease

A Asim, A Kumar, S Muthuswamy, S Jain… - Journal of biomedical …, 2015 - Springer
Down syndrome (DS) is one of the commonest disorders with huge medical and social cost.
DS is associated with number of phenotypes including congenital heart defects, leukemia …

New insights into mechanisms behind miscarriage

EC Larsen, OB Christiansen, AM Kolte, N Macklon - BMC medicine, 2013 - Springer
Sporadic miscarriage is the most common complication of early pregnancy. Two or three
consecutive pregnancy losses is a less common phenomenon, and this is considered a …

Screening for fetal aneuploidies at 11 to 13 weeks

KH Nicolaides - Prenatal diagnosis, 2011 - Wiley Online Library
Effective screening for major aneuploidies can be provided in the first trimester of
pregnancy. Screening by a combination of fetal nuchal translucency and maternal serum …

Estimates of the live births, natural losses, and elective terminations with Down syndrome in the United States

G De Graaf, F Buckley… - American Journal of …, 2015 - Wiley Online Library
The present and future live birth prevalence of Down syndrome (DS) is of practical
importance for planning services and prioritizing research to support people living with the …

Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities

KH Nicolaides - American journal of obstetrics and gynecology, 2004 - Elsevier
There is extensive evidence that effective screening for major chromosomal abnormalities
can be provided in the first trimester of pregnancy. Prospective studies in a total of 200,868 …

The four ages of Down syndrome

AH Bittles, C Bower, R Hussain… - The European Journal of …, 2007 - academic.oup.com
Background: Down syndrome (DS) affects∼ 1 per 650–1000 live births and is the most
common known genetic cause of intellectual disability. A highly significant change in the …

Clinical, social, and ethical implications of changing life expectancy in Down syndrome

AH Bittles, EJ Glasson - Developmental medicine and child …, 2004 - cambridge.org
Between 1 and 4% of the populations of developed nations are diagnosed with learning
disability. In Australia, an estimated 1.9% of the population exhibit learning disability either …

First-trimester screening for trisomies 21 and 18

R Wapner, E Thom, JL Simpson… - … England Journal of …, 2003 - Mass Medical Soc
Background Screening for aneuploid pregnancies is routinely performed after 15 weeks of
gestation and has a sensitivity of approximately 65 percent, with a false positive rate of 5 …

Revised estimates of the maternal age specific live birth prevalence of Down's syndrome

JK Morris, DE Mutton… - Journal of medical …, 2002 - journals.sagepub.com
Objectives: To revise the estimates of maternal age specific live birth prevalence of Down's
syndrome in the absence of antenatal screening and selective termination using newly …